BiocompCHATibility

BiocompCHATibility

Por: BiocompCHATibility
BiocompCHATibility Podcast, Presented by NAMSA Unforeseen challenges and roadblocks are often present when managing and conducting medical device biological safety programs. Join NAMSA for a first-of-its-type podcast series, “BiocompCHATibility,” as each episode features leading industry experts and discussion on how to proactively address specific medical device evaluation scenarios, regulatory expectations and new testing methodologies.
38 episodios disponibles

Latest episodes of the podcast BiocompCHATibility

Navigating Biocompatibility in Early Feasibility Studies 22/07/2024
Exploring Equivalency in Biocompatibility 08/07/2024
Chemistry with the MFDS 14/11/2023
New FDA Biocompatibility Guidance – Let’s Discuss 04/10/2023
Welcome to the RA QA Café 07/02/2023
What Exactly is my Test Article? 25/07/2022
FDA Thoughts On Chemical Characterization 28/03/2022
Don’t Forget Packaging! 22/02/2022
Biological Equivalency: When is “same” the same? 22/11/2021
The QB1 of GLP 28/09/2021
Biocomp and Beer 09/08/2021
NAMSA Awarded ASCA Accreditation 28/07/2021
Biocompatibility FAQ 27/05/2021
Why biocompatibility cares about preclinical:  NAMSA and APS discuss 22/03/2021
When to Go with In Vitro: Your Irritation Questions Answered 22/02/2021
Is Your BioCompatibility Program Knocking Your Submission Off Track? 25/01/2021
Oh No, Another Failed Cyto 20/12/2020
Intact Skin Contact Devices: To Test or Not to Test 23/11/2020
What in the world is the FDA’s Lab Accreditation Program – ASCA? 26/10/2020
The Facts About In vitro Irritation 28/09/2020
1 2 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA